Overview

Josh did his undergraduate in Biochemistry at the University of Kent, during which time he took a voluntary role in the research lab of Dr. Dan Mulvihill assessing the growth rate of yeast model cell lines. Following graduation, Josh worked for Eli Lilly and Co. as a neuropathologist researching neurodegenerative conditions through histological analysis of mouse and human samples.

In 2019 Josh joined the Epigenetics of Complex Diseases group at the RILD as a PhD Student under the supervision of Professor Katie Lunnon, Dr. Ehsan Pishva and Professor Jon Mill. The project will focus on profiling epigenomic changes in methylation state associated with Dementia with Lewy bodies and Parkinson’s Disease Dementia.

Qualifications

• BSc Biochemistry: University of Kent (First Class Honours)

• Grants/Funding:

• Charles Wolfson Charitable Trust

• MRC Research Grant (PI Lunnon)

Back to top

Research

Research interests

Neurodegenerative disease, in particular alpha-synucleinopathies. Epigenetics, Neuropathology, Genomics, Neuroscience.

Research projects

Current Projects:

• A role for epigenetic changes in Dementia with Lewy bodies

ResearchGate: https://www.researchgate.net/profile/Joshua_Harvey7

Back to top